Data.
Published in Figshare • Aug 20, 2025
NobleIDNI7P34W58R35S61
Authors:,,
Kenji Suita (750993)
Yoshio Hayakawa (8043413)
Yujiro Hoshino (2982723)
Abstract
The worldwide standard guideline for treating heart failure (HF) is inhibition of the patients’ chronically enhanced sympathetic nervous system activity. However, despite gains in the treatment of HF with angiotensin and β-adrenergic receptor (β-AR) blockers, some patients do not tolerate β-AR block...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!